Insider and congress filings

Zoetis Inc. (ZTS)

NYSE · Healthcare · 392 insider filings · 195 congress trades · last filed 7 days agoS&P 500

3
Open-market insider filings shown
0d
Median delay on the insider filings
within the two business day rule
3/0
Purchases and sales in the filings shown

About Zoetis Inc.

from the company's filings and listing
Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chief executive
Kristin C. Peck
Employees
14,500
Listed since
Feb 1, 2013
Market value
$30.7B
Price to earnings
12.1
Earnings per share
$6.26
Dividend yield
2.85%

www.zoetis.com

Earnings

6 reported quarters · next on Nov 3, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 6, 2026$1.87$1.85$2.5B$2.5BEPS in lineRevenue in line
Q1 FY2026reported May 7, 2026$1.53$1.60$2.3B$2.3BEPS missRevenue miss
Q4 FY2025reported Feb 12, 2026$1.48$1.40$2.4B$2.4BEPS beatRevenue in line
Q3 FY2025reported Nov 4, 2025$1.70$1.62$2.4B$2.4BEPS beatRevenue in line
Q2 FY2025reported Aug 5, 2025$1.76$1.62$2.5B$2.4BEPS beatRevenue beat
Q1 FY2025reported May 6, 2025$1.48$1.41$2.2B$2.2BEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2024 · proxy filed Apr 9, 2025
ExecutiveSalaryStock awardsOtherTotal
Kristin C. PeckChief Executive Officer$1.3M$9.6M$6.3M$17.2M
Wetteny JosephExecutive Vice President (“EVP”) and Chief Financial O$750K$2.4M$1.9M$5.1M
Jamie BrannanEVP and Chief Commercial Officer$659K$911K$1.5M$3.0M
Robert J. PolzerEVP and President of Research and Development$660K$1.1M$1.2M$3.0M
Roxanne LaganoEVP, General Counsel and Corporate Secretary$621K$937K$1.1M$2.6M

The summary compensation table from the 2024 proxy statement, current executives only. 2 executives who have since left the company are named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$2.8B39,430,181+10.8%9.44%
Vanguard Capital Management LLC$1.9B26,027,984-0.2%6.23%
Vanguard Portfolio Management LLC$1.7B23,860,445-0.4%5.71%
State Street Corp$1.4B19,667,723+1.8%4.71%
State Farm Mutual Automobile Insurance Co$1.1B15,892,9030.0%3.81%
Geode Capital Management, LLC$951.8M13,289,622+17.1%3.18%
Wellington Management Group LLP$677.2M9,423,895-7.2%2.26%
Morgan Stanley$638.0M8,878,849-37.2%2.13%
Nordea Investment Management Ab$471.7M6,592,578+12.4%1.58%
Deutsche Bank Ag\$420.5M5,851,737+5.8%1.40%
Northern Trust Corp$398.3M5,542,234-0.1%1.33%
Invesco Ltd.$396.9M5,523,018+56.0%1.32%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next ZTS filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

3 filings of 392 on record
InsiderActionSharesPriceValueTrade dateDelay
Frank A. DamelioDirectorBought6,650$75.39$501KMay 13, 20260d
Paul BisaroDirectorBought2,000$75.88$152KMay 13, 20260d
Michael B. MccallisterDirectorBought3,000$77.76$233KMay 11, 20261d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Congress trades in ZTS

20 disclosures of 195 on record · median 24d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Gilbert Ray Cisneros, Jr.Filed lateStockSale$1,001 - $15,000-4.2%S&P +2.6% · vs S&P 500 -6.8%Jul 17, 2026Sep 4, 202649d
Ro KhannaStockPurchase$1,001 - $15,000-4.6%S&P +1.1% · vs S&P 500 -5.7%Aug 3, 2026Sep 4, 202632d
Ro KhannaStockPurchase$1,001 - $15,000-3.9%S&P +2.0% · vs S&P 500 -5.9%Jul 7, 2026Aug 7, 202631d
Ro KhannaStockSale$1,001 - $15,000-3.8%S&P +2.7% · vs S&P 500 -6.5%Jul 20, 2026Aug 7, 202618d
Byron DonaldsSpouseStockPurchase$1,001 - $15,000-10.8%S&P +3.4% · vs S&P 500 -14.2%Jun 9, 2026Jul 15, 202636d
Ro KhannaStockPurchase$1,001 - $15,000-7.6%S&P +1.6% · vs S&P 500 -9.2%Jun 16, 2026Jul 6, 202620d
Ro KhannaStockPurchase$1,001 - $15,000+2.0%S&P +2.1% · vs S&P 500 0.0%Jun 30, 2026Jul 6, 20266d
Ro KhannaStockSale$1,001 - $15,000-4.0%S&P +0.4% · vs S&P 500 -4.4%Jun 2, 2026Jul 6, 202634d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000-7.6%S&P +1.6% · vs S&P 500 -9.2%Jun 16, 2026Jul 2, 202616d
Ro KhannaStockSale$1,001 - $15,000-7.8%S&P +1.6% · vs S&P 500 -9.3%May 27, 2026Jun 9, 202613d
Ro KhannaStockPurchase$1,001 - $15,000-1.2%S&P +3.2% · vs S&P 500 -4.4%May 15, 2026Jun 9, 202625d
Ro KhannaStockPurchase$1,001 - $15,000-35.8%S&P +5.8% · vs S&P 500 -41.6%May 1, 2026Jun 9, 202639d
Ro KhannaStockPurchase$1,001 - $15,000-37.3%S&P +6.8% · vs S&P 500 -44.0%Apr 24, 2026May 11, 202617d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-39.5%S&P +9.8% · vs S&P 500 -49.3%Apr 14, 2026May 8, 202624d
Ro KhannaStockSale$1,001 - $15,000-37.0%S&P +20.7% · vs S&P 500 -57.6%Mar 30, 2026Apr 7, 20268d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000-36.6%S&P +15.1% · vs S&P 500 -51.7%Mar 13, 2026Apr 7, 202625d
Ro KhannaStockSale$1,001 - $15,000-36.4%S&P +16.0% · vs S&P 500 -52.3%Mar 23, 2026Apr 7, 202615d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000-42.8%S&P +10.1% · vs S&P 500 -52.9%Feb 10, 2026Mar 9, 202627d
Ro KhannaStockPurchase$1,001 - $15,000-41.2%S&P +9.9% · vs S&P 500 -51.0%Jan 13, 2026Feb 6, 202624d
Ro KhannaStockSale$15,001 - $50,000-39.1%S&P +11.8% · vs S&P 500 -50.8%Jan 22, 2026Feb 6, 202615d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

7 members · estimate, as of Sep 10, 2026

7 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Byron DonaldsRepublican · House$15,001 - $50,0004.1%
Markwayne MullinRepublican · Senate$1,001 - $15,0000.1%
Gilbert Ray Cisneros, Jr.Democrat · House$1,001 - $15,000<0.1%
Andrew R. GarbarinoRepublican · House$1,001 - $15,00019.6%
Robert BresnahanRepublican · House$1,001 - $15,000<0.1%
Robert J. WittmanRepublican · House$1,001 - $15,0000.5%
Shelley Moore CapitoRepublican · Senate$1,001 - $15,0000.2%

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Awards, option exercises and gifts (20)
InsiderEventSharesDate
James SaccaroEVP, CFO & COOStock award81,063Aug 31, 2026
Frank A. DamelioDirectorGift6,650Aug 7, 2026
Kevin EschExecutive Vice PresidentStock award308Jul 10, 2026
Kristin C. PeckChief Executive OfficerStock award616Jul 10, 2026
Keith SarbaughExecutive Vice PresidentStock award260Jul 10, 2026
Julie FullerExecutive Vice PresidentStock award315Jul 10, 2026
Wetteny JosephChief Financial OfficerStock award363Jul 10, 2026
Roxanne LaganoExecutive Vice PresidentStock award315Jul 10, 2026
Abhay U. NayakExecutive Vice PresidentStock award215Jul 10, 2026
Astorga Jeannette FerranExecutive Vice PresidentStock award45Jul 10, 2026
Rimma DriscollExecutive Vice PresidentStock award238Jul 10, 2026
Mark StetterDirectorStock award318Jun 18, 2026
Abhay U. NayakExecutive Vice PresidentForm 424,025Jun 15, 2026
Michael B. MccallisterDirectorGift1,209Jun 10, 2026
Mark StetterDirectorOption exercise3,144May 21, 2026
Louise M. ParentDirectorOption exercise24,261May 20, 2026
Kevin EschExecutive Vice PresidentOption exercise519Apr 30, 2026
Kevin EschExecutive Vice PresidentTax withholding75Apr 30, 2026
Julie FullerExecutive Vice PresidentStock award551Apr 10, 2026
Kevin EschExecutive Vice PresidentStock award1Apr 10, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling ZTS?

Across the 3 most recent open-market filings shown here, 3 were purchases and 0 were sales.

Which members of Congress have traded ZTS?

Gilbert Ray Cisneros, Jr., Ro Khanna, Byron Donalds disclosed ZTS transactions in the filings shown here.

Which members of Congress hold ZTS?

7 members of Congress report a position in ZTS in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Byron Donalds, Markwayne Mullin and Gilbert Ray Cisneros, Jr.. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is ZTS in the S&P 500 or the Nasdaq 100?

Zoetis Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.

How quickly are ZTS trades disclosed?

Insider filings on this page reached the public a median of 0 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 24 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track